Explore more publications!

Press Releases

Imviva Biotech Announces Seven Presentations Highlighting its ANSWER™ Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting
DevLand Sets The New Standard for AI Safety in Education Following Documented Failures Affecting Over 450,000 Students
New State-by-State Analysis Reveals Where America’s 2 Trillion Dollar Burnout Crisis Hits Hardest
Oncology Devices Market to Surge USD 776.3 Billion at 17.84% CAGR by 2034
Toll Brothers Offering Sneak Peek Tours of Woodinville Square Model Homes in Woodinville, Washington
Helport AI and UMass Lowell Launch AI Entrepreneurship Competition
Needles Market Set to Boom: Strategic Insights and Growth Opportunities with Key Players Abbott, Becton, Medtronic
Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
Operations Advisory Market Forecasted to Achieve US $352.99 Billion by 2029
reAlpha (Nasdaq: AIRE) Acquires Prevu to Expand Multi-State Footprint and Offer Its Integrated Realty and Mortgage Services in Additional States
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
Cabot Corporation Announces Reinforcement Materials Segment Executive Transition
More Europe, More Travel: Air Canada Further Expands Network to Offer North America’s Second Largest Transatlantic Network by Destinations
Artificial Blood Substitute Market Surges USD 62.54 Million by 2034 Amid Rising Emergencies and Innovation
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Mayor Michelle Wu Announces Youth Jobs Applications Open for 2025-2026 School Year

Mayor Michelle Wu Announces Youth Jobs Applications Open for 2025-2026 School Year

The Egyptian Credit Bureau 'iscore' Honored with Prestigious 'Pioneer of AI-Driven Credit Transformation' Award
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Weekly Traffic Update: November 26, 2025

Weekly Traffic Update: November 26, 2025

Radiation Oncology Market Size Expected to Reach USD 36.78 Bn at 11.44% CAGR by 2035

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions